Journal
ANTIVIRAL RESEARCH
Volume 178, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2020.104791
Keywords
Interferon; COVID-19; SARS-CoV-2
Categories
Ask authors/readers for more resources
Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
